Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Amphotericin B Nephrotoxicity
NCT06122311Completed
- Sponsor
- Helwan University
- Start
- Aug 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetylcysteine in nephropathy (2 arms), sponsored by Helwan University. Primary endpoint: Incidence of Nephrotoxicity. Started Aug 2023; status: completed.
02
Drugs
acetylcysteine
03
Conditions
nephropathy
Beyond the preview
Go deeper on NCT06122311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06122311.